Peptide Initiative

Peptides · Peptide comparison

GHK-Cu (Copper Peptide) vs Myristoyl Pentapeptide-17

A naturally occurring copper peptide that acts like a master switch for your body's repair systems—boosting collagen production, accelerating wound healing, and helping your skin rebuild itself from the inside out [1][4].

Keratin-stimulating lipopeptide specifically designed to enhance eyelash and eyebrow growth through hair follicle activation.

  • Cosmetic
  • Cosmetic

At a glance

Quick comparison

Dose rangeGHK-Cu (Copper Peptide)0.1–0.1 %Myristoyl Pentapeptide-170.001–0.1 %
FrequencyGHK-Cu (Copper Peptide)Once or twice daily, topicalMyristoyl Pentapeptide-17Once daily
AdministrationGHK-Cu (Copper Peptide)Subcutaneous injectionMyristoyl Pentapeptide-17Topical
Cycle lengthGHK-Cu (Copper Peptide)12 weeks, then ongoingMyristoyl Pentapeptide-17Ongoing/indefinite
Onset speedGHK-Cu (Copper Peptide)Moderate (1-2 weeks)Myristoyl Pentapeptide-17Moderate (1-2 weeks)
Evidence levelGHK-Cu (Copper Peptide)Strong preclinical (extensive animal studies)Myristoyl Pentapeptide-17Limited human trials

Efficacy

Benefit ratings

Skin Rejuvenation

GHK-Cu (Copper Peptide)96%
Myristoyl Pentapeptide-17No recorded rating

Wound Healing

GHK-Cu (Copper Peptide)94%
Myristoyl Pentapeptide-17No recorded rating

Tissue Regeneration

GHK-Cu (Copper Peptide)91%
Myristoyl Pentapeptide-17No recorded rating

Eyelash Growth

GHK-Cu (Copper Peptide)No recorded rating
Myristoyl Pentapeptide-1785%

Hair Strengthening

GHK-Cu (Copper Peptide)No recorded rating
Myristoyl Pentapeptide-1780%

Safety Profile

GHK-Cu (Copper Peptide)No recorded rating
Myristoyl Pentapeptide-1795%

Technical data

Compound specifications

GHK-Cu (Copper Peptide)

Molecular formula
C14H23N6O4Cu
Molecular weight
403.93 g/mol
Half-life
Approximately 1 hour (plasma)
Bioavailability
High when injected subcutaneously; variable topically depending on formulation
CAS number
49557-75-7

Myristoyl Pentapeptide-17

Molecular formula
C41H81N9O6
Molecular weight
796.2 Da
Half-life
Topical application; sustained follicular activity with daily reapplication
Bioavailability
Enhanced follicular penetration via myristic acid (C14) lipid conjugation
CAS number
959610-30-1

Protocols

Dosing compared

GHK-Cu (Copper Peptide)

Topical

  • 0.1% cream (roughly 1 mg/mL)Once or twice daily to the treatment area · 12 weeks for visible results, then ongoingThis is the only GHK-Cu route with a controlled human trial behind it, and the trial was largely negative. Thirteen patients used a GHK-Cu aftercare regimen after CO2 laser resurfacing; blinded assessment found no significant improvement in redness, wrinkles or overall skin quality versus the control regimen, and only the patients' own rating separated (P = 0.04) [7]. Topical wound-healing evidence beyond that is animal — 24 rats with ischemic wounds, where the copper tripeptide gel reduced wound area faster than vehicle [4]. Concentration matters and is not standardised across products; the figures quoted for cosmetic creams come from industry reports rather than independent trials [1][2].

Subcutaneous

  • No established human doseNot established · Not establishedThere are no human studies of injected GHK-Cu by any systemic route. The GHK-Cu studies registered on ClinicalTrials.gov are topical or transdermal [13]. The 1-2 mg figures circulated for subcutaneous use trace to community practice, not to any published study, and no human toxicology exists for the copper load a systemic dose would deliver. The Pickart literature most often cited for GHK-Cu is mechanistic and wound-repair work, not injectable dosing [1][2][3].

Myristoyl Pentapeptide-17

Topical

  • 0.001-0.1% in finished serum (supplied as a 0.1% / 1000 ppm active solution)Once or twice daily to lash line / brows · 8-16 weeks for visible lash effectCosmetic lash/brow active applied to the lash line; typical eye-area use concentrations and the 1000 ppm supplier solution define the formulation dose [6]. Topical only; not dosed systemically.

Applications

Best suited for

GHK-Cu (Copper Peptide)

Anti-Aging Warriors
If fine lines, sagging skin, and lost elasticity are your enemies, GHK-Cu is your secret weapon. It ramps up collagen and elastin production—the two proteins responsible for keeping your skin firm and youthful [1][2]. Studies show it can tighten loose skin and improve elasticity better than many popular skincare ingredients [1][2].
Wound Healing Champions
Whether you're recovering from surgery, dealing with stubborn wounds, or healing from a cosmetic procedure, GHK-Cu accelerates the entire repair process [4]. It attracts immune cells, builds new blood vessels, and stimulates the growth factors your body needs to rebuild tissue faster and better [1].
Scar Reducers
GHK-Cu doesn't just heal wounds—it helps remodel scar tissue. By regulating how your body lays down collagen during healing, it can help scars become flatter, softer, and more like surrounding normal skin [6]. It even reduces the TGF-beta signals that lead to thick, raised scars [12].
Hair Growth Seekers
Research shows GHK-Cu can enlarge hair follicles and activate the Wnt/beta-catenin pathway—the signaling system that tells hair follicles to grow [1]. If you're noticing thinning hair or increased shedding, this peptide may help stimulate thicker, healthier growth over time.

Myristoyl Pentapeptide-17

Individuals seeking longer, fuller eyelashes without prostaglandin-based prescriptions
Myristoyl Pentapeptide-17 is particularly well-suited for individuals focused on individuals seeking longer, fuller eyelashes without prostaglandin-based prescriptions. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Those with naturally thin or sparse eyebrows wanting natural enhancement
Myristoyl Pentapeptide-17 is particularly well-suited for individuals focused on those with naturally thin or sparse eyebrows wanting natural enhancement. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
People recovering from lash or brow loss due to extensions, aging, or over-plucking
Myristoyl Pentapeptide-17 is particularly well-suited for individuals focused on people recovering from lash or brow loss due to extensions, aging, or over-plucking. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Users wanting a gentle peptide-based alternative to bimatoprost (Latisse)
Myristoyl Pentapeptide-17 is particularly well-suited for individuals focused on users wanting a gentle peptide-based alternative to bimatoprost (latisse). Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.

Safety profile

Side effects

GHK-Cu (Copper Peptide)

Common

  • Injection site redness
  • Skin tingling (topical use)
  • Minor bruising
  • Mild swelling at injection site

Uncommon

  • Mild headache
  • Temporary skin purging (topical)

Serious

  • Allergic reaction

Myristoyl Pentapeptide-17

Common

  • Mild Tingling at Lash Line
  • Temporary Eyelid Dryness
  • Product Residue Buildup
  • Lash Shedding During Initial Phase

Uncommon

  • Periorbital Sensitivity

Serious

  • Allergic Contact Reaction
  • Lipid Peroxidation and Oxidative Stress

Research status

Safety & evidence

GHK-Cu (Copper Peptide)

Evidence level
Strong preclinical (extensive animal studies)
FDA status
Research compound
Safety overview
GHK is a peptide the body makes on its own — it turns up in human blood serum and cerebrospinal fluid, where it binds copper [5]. The peptide's original describer reports that the amount circulating falls with age, from roughly 200 ng/mL around age 20 to about 80 ng/mL by age 60 [2]. That is a description of what declines, not evidence that replacing it does anything. Almost all of the safety evidence is topical or laboratory work. The one randomized human trial of topical GHK-Cu — 13 patients using it after CO2 laser resurfacing — reported no safety problems, but also found no objective benefit over the control regimen [7]. There is no human safety data for injected GHK-Cu by any route [13]. That matters more than usual here, because the molecule carries copper: a systemic dose delivers a copper load, and no human toxicology study has measured what that load does.

Contraindications

  • Wilson's disease or copper metabolism disorders
  • Known allergy to copper or peptide components
  • Active cancer or history of cancer
  • Pregnancy or breastfeeding
  • Children and adolescents

Myristoyl Pentapeptide-17

Evidence level
Limited human trials
FDA status
Research compound
Safety overview
Myristoyl pentapeptide-17 demonstrates excellent cosmetic safety with GRAS/safe-for-use status in topical formulations up to 3% concentration. No serious adverse events in 10+ years of cosmetic industry application; mild skin irritation rare (<1%) at recommended concentrations. Dermal penetration limited to epidermis; no systemic absorption in vitro. Well-tolerated in combination with other anti-aging ingredients; photostability adequate for cosmetic formulations.

Contraindications

  • Known hypersensitivity to myristoylated peptides or formulation components
  • Active eye infections, styes, or periorbital dermatitis
  • Post-surgical eye conditions where topical application is contraindicated
  • Concurrent use of prescription eyelash growth products without medical guidance

Decision guide

Which is right for you?

GHK-Cu (Copper Peptide)

Choose GHK-Cu (Copper Peptide) if…

  • Skin rejuvenation and anti-aging
  • Wound and injury recovery
  • Scar reduction
  • Hair growth support

Myristoyl Pentapeptide-17

Choose Myristoyl Pentapeptide-17 if…

  • Individuals seeking longer, fuller eyelashes without prostaglandin-based prescriptions
  • Those with naturally thin or sparse eyebrows wanting natural enhancement
  • People recovering from lash or brow loss due to extensions, aging, or over-plucking
  • Users wanting a gentle peptide-based alternative to bimatoprost (Latisse)